Cancers, Vol. 13, Pages 4480: Poor Neutralizing Antibody Responses in 132 Patients with CLL, NHL and HL after Vaccination against SARS-CoV-2: A Prospective Study
In conclusion, patients with CLL/lymphomas have low humoral response following COVID-19 vaccination, underlining the need for timely vaccination ideally during a treatment-free period and for continuous vigilance on infection control measures.
Source: Cancers - Category: Cancer & Oncology Authors: Evangelos Terpos Maria Gavriatopoulou Despina Fotiou Chara Giatra Ioannis Asimakopoulos Maria Dimou Aimilia D. Sklirou Ioannis Ntanasis-Stathopoulos Ismini Darmani Alexandros Briasoulis Efstathios Kastritis Maria Angelopoulou Ioannis Baltadakis Panayiotis Tags: Article Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Chemotherapy | Chronic Leukemia | Chronic Lymphocytic Leukemia | COVID-19 | Hematology | Leukemia | Lymphoma | Rituxan | SARS | Study | Vaccines